Capital International Investors Portfolio holdings
Capital International, established in 1968 as a division of the Los Angeles-based Capital Group, is a global investment management firm focused on delivering equity investment solutions for institutional and individual clients worldwide. Operating as part of one of the oldest and largest asset managers, founded in 1931, it leverages Capital Group’s signature research-driven, long-term investment philosophy, managing billions in assets through a multi-manager system that diversifies risk and enhances performance. Headquartered in Los Angeles with a presence across North America, Europe, and Asia, Capital International specializes in international and global equity strategies, often through mutual funds like those in the American Funds family. Known for its rigorous fundamental analysis and commitment to client outcomes, it plays a key role in Capital Group’s mission to provide consistent, superior returns in global markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$294M |
| 2 |
Duke Energy
DUK
|
+$242M |
| 3 |
Texas Instruments
TXN
|
+$224M |
| 4 |
Verizon
VZ
|
+$189M |
| 5 |
ConocoPhillips
COP
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$220M |
| 2 |
Moody's
MCO
|
+$159M |
| 3 |
DuPont de Nemours
DD
|
+$128M |
| 4 |
Blackrock
BLK
|
+$122M |
| 5 |
Dominion Energy
D
|
+$96.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.13% |
| 2 | Industrials | 11.34% |
| 3 | Technology | 10.65% |
| 4 | Financials | 10.27% |
| 5 | Energy | 9.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Texas Instruments
TXN
$261B
| $980M | 2.64% |
20,775,759
+5,084,200
| +32% | +$224M |
|
2
Microsoft
MSFT
$3.71T
| $888M | 2.39% |
21,661,107
-1,741,000
| -7% | -$65.3M |
|
3
Bristol-Myers Squibb
BMY
$132B
| $840M | 2.26% |
16,164,300
+144,800
| +0.9% | +$7.7M |
|
4
Gilead Sciences
GILD
$165B
| $739M | 1.99% |
10,428,800
+341,100
| +3% | +$26.8M |
|
5
AbbVie
ABBV
$435B
| $713M | 1.92% |
13,877,175
+3,504,900
| +34% | +$177M |
|
6
Home Depot
HD
$355B
| $681M | 1.83% |
8,602,502
+1,225,800
| +17% | +$97.5M |
|
|
7
DuPont de Nemours
DD
$19.2B
| $656M | 1.77% |
5,335,174
-1,085,809
| -17% | -$128M |
|
8
Oracle
ORCL
$423B
| $617M | 1.66% |
15,091,500
+707,500
| +5% | +$26.9M |
|
9
Chevron
CVX
$366B
| $614M | 1.65% |
5,166,450
+1,155,600
| +29% | +$134M |
|
10
Merck
MRK
$318B
| $614M | 1.65% |
11,329,907
+419
| +0% | +$21.7K |
|
|
11
ConocoPhillips
COP
$141B
| $607M | 1.63% |
8,621,360
+2,715,100
| +46% | +$182M |
|
|
12
Verizon
VZ
$196B
| $586M | 1.58% |
12,324,638
+3,998,641
| +48% | +$189M |
|
13
Pfizer
PFE
$153B
| $573M | 1.54% |
18,803,098
+1,439,554
| +8% | +$42.9M |
|
14
Coca-Cola
KO
$375B
| $554M | 1.49% |
14,323,400
+1,574,200
| +12% | +$60.8M |
|
|
15
Procter & Gamble
PG
$339B
| $548M | 1.47% |
6,799,600
+3,728,700
| +121% | +$294M |
|
16
RTX Corp
RTX
$301B
| $420M | 1.13% |
5,711,184
-207,682
| -4% | -$14.9M |
|
|
17
Duke Energy
DUK
$97.3B
| $408M | 1.1% |
5,724,482
+3,466,969
| +154% | +$242M |
|
18
SLB Ltd
SLB
$75B
| $399M | 1.07% |
4,097,400
+1,082,400
| +36% | +$97.9M |
|
19
Wells Fargo
WFC
$264B
| $376M | 1.01% |
7,564,800
+3,274,800
| +76% | +$153M |
|
20
Carnival Corporation Ltd
CCL
$39.7B
| $362M | 0.97% |
9,564,100
| – | – |
|
21
Goldman Sachs
GS
$303B
| $360M | 0.97% |
2,199,100
+892,900
| +68% | +$150M |
|
22
Newell Brands
NWL
$2.56B
| $359M | 0.97% |
12,000,800
+1,818,700
| +18% | +$56.4M |
|
23
The Mosaic Company
MOS
$7.33B
| $357M | 0.96% |
7,147,100
+868,200
| +14% | +$41.4M |
|
24
Altria Group
MO
$114B
| $350M | 0.94% |
9,348,000
| – | – |
|
25
Amgen
AMGN
$222B
| $349M | 0.94% |
2,828,248
-156,800
| -5% | -$19M |
|
Similar funds
Capital International Investors's Q1 2014 Portfolio in Review
As of Q1 2014, Capital International Investors held 228 positions worth $37.2B, up 15% from $32.2B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Capital International Investors deployed $4.81B of net new capital in Q1 2014, opening 26 new positions and adding to 72 existing holdings. Its largest new stake was Veren: 4,853,718 shares worth $162M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was Moody's, an estimated $159M trimmed.
- Capital International Investors's largest Q1 2014 buy was Veren: 4,853,718 shares worth $162M.
- Capital International Investors added most to Procter & Gamble in Q1 2014, an estimated $294M increase.
- Capital International Investors's biggest Q1 2014 reduction was Moody's, cutting an estimated $159M.
- Capital International Investors fully exited Celgene Corp in Q1 2014, selling an estimated $220M.
- Capital International Investors's ten largest holdings make up 20% of its $37.2B portfolio in Q1 2014.
- Capital International Investors opened 26 new positions and closed 10 in Q1 2014.
- Capital International Investors's portfolio value rose 15% quarter-over-quarter to $37.2B.
Based on Capital International Investors's 13F filing for Q1 2014, filed 15 May 2014.